Expression of Inflammatory Proteins in Pancreatic Cancer

This study is currently recruiting participants.

Verified by University of Zurich, October 2007

Sponsored by:	University of Zurich
Information provided by:	University of Zurich
ClinicalTrials.gov Identifier:	NCT00551057

Purpose

The purpose of this trial is to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue.

Condition	Intervention
Pancreatic Neoplasms	Behavioral: Expression type

MedlinePlus related topics: Cancer Pancreatic Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Expression of Inflammatory Proteins in Pancreatic Cancer

Further study details as provided by University of Zurich:

Biospecimen Retention: None Retained

Biospecimen Description:

To investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Estimated Enrollment:	150
Study Start Date:	October 2007
Estimated Study Completion Date:	October 2012

Intervention Details:

to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Detailed Description:

Purpose: to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Trial with surgical intervention

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients with pancreatic cancer or chronic pancreatitis

Criteria

Inclusion criteria:

Patients with pancreatic cancer or chronic pancreatitis

Exclusion criteria:

Patients with alpha 1-antitrypsin deficiency

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00551057

Contacts

Contact: Marc Schiesser, MD

+41 (0)44 255 11 11

marc.schiesser@usz.ch

Locations

Switzerland
University Hospital Zurich Department of Surgery	Recruiting
Zurich, Switzerland
Contact: Marc Schiesser marc.schiesser@usz.ch

Sponsors and Collaborators

University of Zurich

Investigators

Principal Investigator:

Marc Schiesser, MD

UniversitaetsSpital Zuerich

More Information

Study ID Numbers:	13-2007
Study First Received:	October 29, 2007
Last Updated:	October 29, 2007
ClinicalTrials.gov Identifier:	NCT00551057
Health Authority:	Switzerland: Swissmedic

Study placed in the following topic categories:

Digestive System Diseases
Digestive System Neoplasms
Pancreatic Neoplasms
Endocrine System Diseases

Pancreatic Diseases
Gastrointestinal Neoplasms
Endocrinopathy
Endocrine Gland Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 15, 2009